We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Mouse Model for Retinoblastoma Research

By Biotechdaily staff writers
Posted on 06 Apr 2004
Cancer researchers working with mice have learned that the tumor suppressor Rb protein, which when lacking can trigger retinoblastoma in young children, limits the proliferation of immature retinal cells in developing embryos and prompts specific cells to mature into light-sensitive retinal rods.

The role of Rb in the developing mouse retina had not been studied previously, as Rb-deficient embryos die before the retinas are fully formed. More...
In the current work, investigators at St. Jude Children's Research Hospital (Memphis, TN, USA) devised several new approaches for studying Rb. These techniques include methods for knocking out Rb expression in cultured mouse retinal cells, as well as methods for knocking out Rb in single retinal progenitor cells so the effect of this mutation could be studied in both embryos and newborn mice.

A viral vector was used to insert the gene for E1A-a protein that inactivates Rb in newborn mice, whose retinas continue to develop after birth. The retinas in these newborn mice grew abnormally large and failed to develop rods. The investigators reported in the February 29, 2004, online edition of Nature Genetics that Rb was required for both proper regulation of retinal cell proliferation and for initiation of rod formation.

"Our work has also included efforts to develop a mouse model that has the same genetic mutations as those found in humans with retinoblastoma yet permits the mouse to develop and be born,” explained senior author Dr. Michael A. Dyer, assistant professor of neurobiology at St. Jude Children's Research Hospital. "This will further enhance our understanding of this devastating cancer and allow us to test new treatments that will spare children with this cancer from losing one or both eyes.”




Related Links:
St. Jude Children's Research Hospital

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Chromogenic Culture System
InTray™ COLOREX™ ECC
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Simple Whole-Blood Screen Identifies Elevated Bile Acids Linked to Liver Disease

Liver disease can progress silently until treatment options become more limited. Routine blood panels measure markers such as cholesterol, bilirubin, and triglycerides but typically do not include bile... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.